CVS Health Corp has submitted its latest 13F-HR filing, detailing its investment holdings as of September 30, 2026. This filing is significant as it provides insights into the company’s investment strategy and portfolio management within the retail-drug store sector.

CVS Health Corp, identified by the CIK 0000064803, operates primarily in the retail-drug stores and proprietary stores sector, classified under SIC 5912. The company trades on the New York Stock Exchange under the ticker CVS. Recently, CVS has filed various forms, including a 10-Q and multiple 8-Ks, indicating ongoing activity and reporting requirements.

The 13F-HR filing, dated November 5, 2026, shows a total value of approximately $429,355,358 across 36 reported holdings. The filing states, "The report type is 13F HOLDINGS REPORT," confirming the nature of the submission. Michael Motolo, the Executive Director of CVS Health, signed the document, which also provides the company’s address in Woonsocket, Rhode Island.

This filing may have implications for various stakeholders, including investors and analysts who track CVS’s investment strategies. The reported holdings could influence perceptions of CVS's market position and competitive strategies within the retail-drug store industry.

The filing does not specify what actions CVS Health may take next following this report. Investors and analysts will likely await further updates and filings to gauge the company's future directions.